Related Experiment Video
Updated: Mar 3, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Association between Fatty Liver Disease and Hyperplastic Colonic Polyp.
Mahmud Mahamid1,2, Tarik Yassin3, Omar Abu Elheja1
1Department of Internal Medicine, Holy Family Hospital, Nazareth, Israel.
Non-alcoholic steatohepatitis (NASH) is linked to a higher incidence of hyperplastic polyps (HPs) in the colon. This study found that patients with biopsy-proven NASH had a significantly increased risk of developing HPs.
Area of Science:
- Gastroenterology
- Hepatology
- Pathology
Background:
- Hyperplastic polyps (HPs) are the most common type of colorectal polyp.
- Metabolic syndrome, including obesity and hyperlipidemia, is implicated in HP development and fatty liver disease pathogenesis.
Purpose of the Study:
- To investigate the association between biopsy-proven steatohepatitis and hyperplastic colonic polyps.
Main Methods:
- Retrospective cohort observational study at Holy Family Hospital, Nazareth, Israel.
- Included 223 patients undergoing screening colonoscopy over two years.
- Data extracted included demographics, medical history, laboratory results, and liver biopsy findings.
Main Results:
- 123 patients had non-alcoholic steatohepatitis (NASH), and 100 served as controls.
- Hyperplastic polyps were found in 22.7% of NASH patients versus 8% of controls (P < 0.05).
- Multivariate analysis revealed NASH is associated with an increased risk for HPs (OR 1.69, P < 0.01).
Conclusions:
- A significant association exists between biopsy-proven steatohepatitis and an increased burden of hyperplastic polyps.
- This finding suggests a potential link between liver health and colorectal polyp development.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

